Catherine Drach

Catherine Drach is a seasoned professional in the biopharmaceutical industry, currently serving as Senior Director for Global Quality E2E and Global Quality Transformation at Sobi - Swedish Orphan Biovitrum AB since October 2021. Prior to this role, extensive experience was gained at Novartis from February 2001 to September 2021, where Catherine held various positions including Quality Integration Lead, responsible for integrating quality compliance of acquired assets, and Quality Lead for CMO Biologics, overseeing the quality practices of biologics and aseptic products. Additional roles at Novartis encompassed QA Expert in Manufacturing Science & Technology and QA Release Responsible, highlighting a strong focus on compliance, risk assessment, and team leadership within quality control and assurance frameworks. Catherine's career commenced at Allerbio as a Quality Control Assistant. Educational qualifications include degrees in Pharmacy and a Master's in Microbiology from the University of Strasbourg.